Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
IQVIA Holdings, Inc. Common Stock
(NY:
IQV
)
149.43
-3.86 (-2.52%)
Streaming Delayed Price
Updated: 3:49 PM EDT, May 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about IQVIA Holdings, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13
May 07, 2025
From
IQVIA Holdings Inc.
Via
Business Wire
Top S&P500 movers in Wednesday's session
May 07, 2025
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive...
Via
Chartmill
What's going on in today's session: S&P500 movers
May 07, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
Via
Chartmill
Earnings Scheduled For May 6, 2025
May 06, 2025
Via
Benzinga
Stocks Fall On Trade Concerns, Oil And Gold Rally: What's Driving Markets Tuesday?
May 06, 2025
Wall Street edged lower by midday Tuesday as uncertainty surrounding trade policies lingered, with investors adopting a cautious approach ahead of Wednesday’s Federal Reserve meeting.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
IQVIA Beats Q1 Earnings Expectations Despite Sector Uncertainty, Company Navigating Market Conditions 'Effectively' Says CEO
May 06, 2025
IQVIA reports Q1 EPS of $2.70 and revenue of $3.83 billion, raises 2025 sales outlook and highlights strong growth in analytics and R&D pipeline metrics.
Via
Benzinga
Wondering what's happening in today's S&P500 pre-market session?
May 06, 2025
Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics.
Via
Chartmill
IQVIA (NYSE:IQV) Beats Q1 Sales Targets, Full-Year Sales Guidance is Optimistic
May 06, 2025
Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 2.5% year on year to $3.83 billion. The company’s full-year revenue...
Via
StockStory
IQVIA Reports First-Quarter 2025 Results
May 06, 2025
From
IQVIA Holdings Inc.
Via
Business Wire
IQVIA (IQV) Q1 Earnings Report Preview: What To Look For
May 05, 2025
Clinical research company IQVIA (NYSE: IQV) will be reporting earnings tomorrow before the bell. Here’s what to expect.
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?
May 01, 2025
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?
Via
Investor's Business Daily
Topics
Animal Testing
Economy
Government
Exposures
Animal Testing
Economy
Political
Tuesday's pre-market session: top gainers and losers in the S&P500 index
April 29, 2025
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Via
Chartmill
IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards
April 28, 2025
From
IQVIA
Via
Business Wire
Beyond The Numbers: 12 Analysts Discuss IQVIA Hldgs Stock
April 25, 2025
Via
Benzinga
Get insights into the top movers in the S&P500 index of Friday's pre-market session.
April 25, 2025
Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session.
Via
Chartmill
3 Healthcare Stocks That Concern Us
April 25, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...
Via
StockStory
Topics
Stocks
Exposures
COVID-19
US Equities
IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm
April 23, 2025
From
IQVIA
Via
Business Wire
IQVIA to Announce First-Quarter 2025 Results on May 6, 2025
April 21, 2025
From
IQVIA
Via
Business Wire
Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report
April 15, 2025
From
IQVIA Holdings Inc.
Via
Business Wire
Alphabet To $185? Here Are 10 Top Analyst Forecasts For Thursday
April 10, 2025
Via
Benzinga
These S&P500 stocks have an unusual volume in today's session
April 09, 2025
Curious about which S&P500 stocks are generating unusual volume on Wednesday? Find out below.
Via
Chartmill
These S&P500 stocks are gapping in today's session
April 09, 2025
Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.
Via
Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
March 31, 2025
Curious about the market action on Monday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
Via
Chartmill
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
March 26, 2025
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest...
Via
StockStory
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks
March 25, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers.
Via
StockStory
3 Reasons IQV is Risky and 1 Stock to Buy Instead
March 19, 2025
IQVIA’s stock price has taken a beating over the past six months, shedding 22.2% of its value and falling to $190.42 per share. This may have investors wondering how to approach the situation.
Via
StockStory
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)
March 18, 2025
Let’s dig into the relative performance of Fortrea (NASDAQ:FTRE) and its peers as we unravel the now-completed Q4 drug development inputs & services earnings season.
Via
StockStory
10 Health Care Stocks Whale Activity In Today's Session
March 11, 2025
Via
Benzinga
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
March 11, 2025
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including Repligen (NASDAQ:RGEN) and...
Via
StockStory
IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services
March 10, 2025
From
IQVIA
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.